Form 8-K - Current report:
SEC Accession No. 0001140361-23-058648
Filing Date
2023-12-20
Accepted
2023-12-20 16:20:48
Documents
19
Period of Report
2023-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20016457_8k.htm   iXBRL 8-K 59873
2 EXHIBIT 4.1 ef20016457_ex4-1.htm EX-4.1 157062
3 EXHIBIT 4.2 ef20016457_ex4-2.htm EX-4.2 91310
4 EXHIBIT 10.1 ef20016457_ex10-1.htm EX-10.1 356929
5 EXHIBIT 10.2 ef20016457_ex10-2.htm EX-10.2 238320
6 EXHIBIT 10.3 ef20016457_ex10-3.htm EX-10.3 95803
7 EXHIBIT 99.1 ef20016457_ex99-1.htm EX-99.1 10744
11 image0.jpg GRAPHIC 9447
  Complete submission text file 0001140361-23-058648.txt   1362638

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA erna-20231214.xsd EX-101.SCH 3866
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE erna-20231214_lab.xml EX-101.LAB 22547
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE erna-20231214_pre.xml EX-101.PRE 16045
13 EXTRACTED XBRL INSTANCE DOCUMENT ef20016457_8k_htm.xml XML 4233
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 231501532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)